Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The source filing: Elanco Animal Health Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001739104-26-000043
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Gross profit | 798 | 713 | 1,583 | 1,397 |
| Research and development | 92 | 92 | 189 | 186 |
| Marketing, selling and administrative | 449 | 400 | 830 | 741 |
| Amortization of intangible assets | 139 | 136 | 277 | 264 |
| Asset impairment, restructuring and other special charges | 9 | 1 | 25 | 10 |
| Interest expense, net of capitalized interest | 59 | 48 | 116 | 88 |
| Other (income) expense, net | (6) | 11 | 3 | 23 |
| Income before income taxes | 56 | 25 | 143 | 85 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Elanco Animal Health Inc.'s D&A?
- Elanco Animal Health Inc. (ELAN) reported D&A of $139M in Q2 2026.
- How has Elanco Animal Health Inc.'s D&A changed year-over-year?
- Elanco Animal Health Inc.'s D&A increased by 2.2% year-over-year, from $136M to $139M.
- What is the long-term trend for Elanco Animal Health Inc.'s D&A?
- Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s D&A has grown at a -0.6% compound annual growth rate (CAGR), from $556M to $543M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Elanco Animal Health Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude